ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 18 of 65 for:    Taste Disorders | NIH

Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02927899
Recruitment Status : Active, not recruiting
First Posted : October 7, 2016
Last Update Posted : May 24, 2018
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Steven Clinton, Ohio State University Comprehensive Cancer Center

Brief Summary:
This study is a sensory analysis of several different formulations of a novel tomato-soy-arugula seed beverage in men with prostate cancer. Eating a diet rich in a variety of fruits and vegetables has been associated with decreased risk of a variety of diseases, including prostate cancer. Mixed vegetable beverages may be useful in prostate cancer survivorship.

Condition or disease Intervention/treatment Phase
Prostate Carcinoma Other: Survey Administration Dietary Supplement: Tomato-Soy Juice Not Applicable

Detailed Description:

PRIMARY OBJECTIVES:

I. To evaluate the sensory acceptability of a novel tomato-soy-arugula seed beverage in men with prostate cancer.

OUTLINE:

Patients receive 4 tomato-soy beverages and 3 labeled arugula seed powder portions. Patients add 1 arugula seed powder portion to each of 3 tomato-soy beverages immediately prior to consumption and they consume 1 beverage without the powder. After each beverage tasting, patients complete a survey on the sensory acceptability of the sample.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 27 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Acceptability in the Taste of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer
Study Start Date : April 2015
Estimated Primary Completion Date : April 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Prevention (dietary intervention, survey)
Patients receive 4 tomato-soy beverages and 3 labeled arugula seed powder portions. Patients add 1 arugula seed powder portion to each of 3 tomato-soy beverages immediately prior to consumption, and they consume 1 beverage without the powder. After each beverage tasting, patients complete a survey on the sensory acceptability of the sample.
Other: Survey Administration
Ancillary studies

Dietary Supplement: Tomato-Soy Juice
Receive tomato-soy beverages with or without varying levels of arugula seed powder




Primary Outcome Measures :
  1. Sensory acceptability of tomato-soy-arugula seed beverages assessed by survey [ Time Frame: Up to 2 years ]
    Mean plus/minus standard deviation will be used to express the results from the acceptability tests and the Just About Right tests. Ranking results will be analyzed by using t-test to obtain determine statistical significance. Significance level of the value will be chosen before statistic tests are conducted, at a value of 5%. A critical value below p < 0.05, will be considered statistically significant.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Have a prostate cancer diagnosis
  • Not be allergic to tomato or tomato products
  • Not be allergic to soy or soy related products
  • Not be allergic to any cruciferous vegetables (e.g.: broccoli, cauliflower, kale, brussels sprouts, arugula/rocket, bok choy, etc.)
  • Voluntarily agree to participate and read the informed consent documents

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02927899


Locations
United States, Ohio
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Investigators
Principal Investigator: Steven Clinton, MD Ohio State University Comprehensive Cancer Center

Additional Information:
Responsible Party: Steven Clinton, Principal Investigator, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier: NCT02927899     History of Changes
Other Study ID Numbers: OSU-15064
NCI-2016-01252 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
P30CA016058 ( U.S. NIH Grant/Contract )
First Posted: October 7, 2016    Key Record Dates
Last Update Posted: May 24, 2018
Last Verified: May 2018

Keywords provided by Steven Clinton, Ohio State University Comprehensive Cancer Center:
Tomato-Soy-Arugula

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases